Dividend Information About Utah Medical Products: Everything You Need to Know Before Its Exdividend Date on Sep 17, 2025

Utah Medical Products (UTMD) has announced its latest dividend distribution of $0.3050 per share, with an ex-dividend date set for Sep 17, 2025. The dividend was officially declared on Jul 29, 2025, and will be paid on Oct 2, 2025. This payment is slightly higher than the average of the company’s last 10 dividend payouts, which stood at $0.2778 per share. The company’s most recent dividend, issued on Jul 3, 2025, also amounted to $0.3050 per share, indicating a consistent cash dividend approach. Investors looking to receive this payout must ensure ownership of the stock before the ex-dividend date, as any purchases made afterward will not be eligible for the upcoming dividend.

Over the past week, several developments have emerged that could influence Utah Medical Products’ market performance and investor sentiment. Analysts noted a bullish signal on UTMD’s 15-minute chart, where a KDJ Golden Cross and a Bullish Marubozu pattern were observed on Sep 12, 2025, at 15:15, suggesting a potential upward shift in momentum. However, the same period also brought a bearish technical indicator, the MACD Death Cross, which may signal caution for traders relying on short-term chart analysis. In addition, institutional investor Nuveen LLC recently acquired a new position in UTMD shares during the first quarter of 2025, indicating growing institutional interest in the company.

Fundamentally, the company has been in the spotlight due to its competitive positioning within the medical equipment and devices sector. While direct comparisons with peers like Merit Medical Systems (MMSI) highlight the importance of innovation and product development, Utah Medical Products continues to strengthen its market presence through consistent dividend distributions and operational stability. As of late, the company has also attracted attention in investment discussions, particularly among those seeking stable dividend champions in the healthcare industry.

In conclusion, Utah Medical Products is demonstrating a balanced approach to shareholder returns and operational growth. With a consistent dividend history and recent technical and institutional signals, the company remains a key player in its sector. Investors should be aware that the ex-dividend date for the upcoming payout is Sep 17, 2025, which marks the final day to purchase the stock and receive the dividend. Any transactions after this date will not qualify for the distribution.